Koers Coloplast A/S Other OTC
Aandelen
CLPBY
US19624Y2000
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 27,04 mld. 3,91 mld. 3,62 mld. | Omzet 2025 * | 29,43 mld. 4,25 mld. 3,94 mld. | Marktkapitalisatie | 190 mld. 27,44 mld. 25,41 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 5,25 mld. 759 mln. 703 mln. | Nettowinst (verlies) 2025 * | 6,12 mld. 885 mln. 820 mln. | EV/omzet 2024 * | 7,72 x |
Nettoschuld 2024 * | 18,94 mld. 2,74 mld. 2,54 mld. | Nettoschuld 2025 * | 17,89 mld. 2,59 mld. 2,4 mld. | EV/omzet 2025 * | 7,06 x |
K/w-verhouding 2024 * |
36,3
x | K/w-verhouding 2025 * |
31
x | Werknemers | - |
Dividendrendement 2024 * |
2,4% | Dividendrendement 2025 * |
2,61% | Vrij verhandelbaar | 58,44% |
Recentste transcriptie over Coloplast A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-01-08 | |
Director of Finance/CFO | 52 | 01-01-06 | |
Chairman | 65 | 01-01-88 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 76 | 01-10-68 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 01-12-17 |
Chairman | 65 | 01-01-88 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-29,83% | 3,13 mld. | |
-18,01% | 2,47 mld. | |
+7,75% | 2,25 mld. | |
+11,11% | 2,16 mld. | |
-3,87% | 2,03 mld. | |
+7,22% | 1,63 mld. | |
+30,81% | 1,31 mld. | |
+10,01% | 1,18 mld. | |
-2,24% | 1,03 mld. |